Severe Deoxyguanosine Kinase Deficiency in Austria: A 6-Patient Series.
Stephanie Waich, Anne Roscher, Michaela Brunner-Krainz...
https://pubmed.ncbi.nlm.nih.gov/30589726/Actively Recruiting
Led by Medical University of Vienna · Updated on 2026-07-28
100
Participants Needed
7
Research Sites
N/A
Total Duration
Rare diseases are a group of over 8,000 serious and often chronic conditions that mostly affect children and adolescents, leading to significant medical and psychosocial challenges. This study evaluates the effectiveness of Education & Care in RARE, a short-term, structured psychoeducational program designed to improve knowledge about rare diseases and mental health well-being among pediatric patients. The trial is a prospective, multicenter, randomized controlled study comparing this program to a waiting list control group. Participants are randomly assigned to either the intervention group, which receives the Education & Care in RARE program immediately, or to a waiting list control group that receives the same program 8 to 12 weeks later. The intervention is delivered one-on-one by trained staff over up to 8 weeks with flexible session numbers and durations. Both groups complete identical questionnaires at multiple time points before and after the intervention to assess knowledge and well-being. During the study, participants attend evaluation appointments where self-rating scales, expert assessments, quality of life questionnaires, and mental health measures are collected at baseline, post-intervention, and follow-up visits extending 3 to 6 months after the intervention. The study also evaluates satisfaction with the program from both participants and experts. The total participation timeline includes initial assessment, intervention delivery, and follow-up periods for comprehensive monitoring.
CONDITIONS
Education & Care in RARE: Efficacy of Targeted Psychoeducational Intervention Among Pediatric Rare Disease Patients
J
Julia Vodopiutz, MD apProf
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Medical University of Vienna
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 8 weeks
Participants receive the Education & Care in RARE psychoeducation program delivered one-on-one by trained staff over up to 8 weeks. The program includes multiple sessions tailored to the participant's needs.
Variable number of sessions during this period
Duration - 3 to 6 months
Participants complete questionnaires and assessments at several time points after the intervention to evaluate changes in knowledge, mental health, and quality of life.
1 to 3 visits for follow-up assessments
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Stephanie Waich, Anne Roscher, Michaela Brunner-Krainz...
https://pubmed.ncbi.nlm.nih.gov/30589726/Stefanie Witt, Kaja Kristensen, Silke Wiegand-Grefe...
https://pubmed.ncbi.nlm.nih.gov/34838091/Nina-Katharina Walleczek, Kristina Förster, Martina Seyr...
https://pubmed.ncbi.nlm.nih.gov/33689085/Lasse Holt-Danborg, Julia Vodopiutz, Annika W Nonboe...
https://pubmed.ncbi.nlm.nih.gov/30445423/Munis Dündar, Thomas Müller, Qi Zhang...
https://pubmed.ncbi.nlm.nih.gov/20004762/Markus Breu, Chiara Häfele, Petra Trimmel-Schwahofer...
https://pubmed.ncbi.nlm.nih.gov/34453316/Simone Baldovino, Antoni Montserrat Moliner, Domenica Taruscio...
https://pubmed.ncbi.nlm.nih.gov/27468531/Illja J Diets, Roos van der Donk, Kristina Baltrunaite...
https://pubmed.ncbi.nlm.nih.gov/30929739/Petra Sackl-Pammer, Zeliha Özlü-Erkilic, Rebecca Jahn...
https://pubmed.ncbi.nlm.nih.gov/30218392/Julia Vodopiutz, Rainer Seidl, Daniela Prayer...
https://pubmed.ncbi.nlm.nih.gov/26123727/Medical University of Vienna
Lead Sponsor